Wolfgang Peter Fendler1, Johannes Czernin1, Ken Herrmann2, Thomas Beyer3. 1. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; and. 2. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; and kherrmann@mednet.ucla.edu. 3. Centre of Medical Physics and Biomedical Engineering, QIMP, Medical University of Vienna, Vienna, Austria.
Abstract
Information has been collected from PET/MRI operational sites to identify its present and future applications. This may help to focus discussions on common interests of the PET/MRI community. METHODS: A web-based survey of PET/MRI users was conducted from June to October 2015. The survey was composed of 26 questions related to the PET/MRI center, present use and imaging protocols, and perspectives on key applications. RESULTS: Responses were collected from 39 international sites that operated PET/MRI for a median of 30 mo (range, 2-62 mo). Most installations were located in public institutions with an academic focus (n = 26, 67%). Systems were primarily operated by nuclear medicine departments (n = 13, 33%), jointly by nuclear medicine and radiology (n = 11, 28%), and radiology only (n = 10, 26%). PET/MRI operation was equally focused on clinic routine and research (47% vs. 45% of sites, respectively). Sites reported a strong focus on oncology (76% of research and 88% of clinical applications). Other applications included neurology (9% clinical, 12% research) and cardiology (3% clinical, 6% research). Perceived superiority over PET/CT was identified as the strongest driver for clinical adoption. Over half the operators expect PET/MRI to excel in clinical routine within 3-5 y. Emerging key applications for future PET/MRI use were cardiovascular disease and imaging of inflammation. CONCLUSION: An international survey of early PET/MR adopters reveals a mixed use of this combined imaging modality, with a focus on oncology. The future of PET/MRI is seen in expanded application for oncology and neurology, but also cardiovascular disease and inflammation.
Information has been collected from PET/MRI operational sites to identify its present and future applications. This may help to focus discussions on common interests of the PET/MRI community. METHODS: A web-based survey of PET/MRI users was conducted from June to October 2015. The survey was composed of 26 questions related to the PET/MRI center, present use and imaging protocols, and perspectives on key applications. RESULTS: Responses were collected from 39 international sites that operated PET/MRI for a median of 30 mo (range, 2-62 mo). Most installations were located in public institutions with an academic focus (n = 26, 67%). Systems were primarily operated by nuclear medicine departments (n = 13, 33%), jointly by nuclear medicine and radiology (n = 11, 28%), and radiology only (n = 10, 26%). PET/MRI operation was equally focused on clinic routine and research (47% vs. 45% of sites, respectively). Sites reported a strong focus on oncology (76% of research and 88% of clinical applications). Other applications included neurology (9% clinical, 12% research) and cardiology (3% clinical, 6% research). Perceived superiority over PET/CT was identified as the strongest driver for clinical adoption. Over half the operators expect PET/MRI to excel in clinical routine within 3-5 y. Emerging key applications for future PET/MRI use were cardiovascular disease and imaging of inflammation. CONCLUSION: An international survey of early PET/MR adopters reveals a mixed use of this combined imaging modality, with a focus on oncology. The future of PET/MRI is seen in expanded application for oncology and neurology, but also cardiovascular disease and inflammation.
Authors: Istvan Szanda; Jane Mackewn; Gergely Patay; Peter Major; Kavitha Sunassee; Gregory E Mullen; Gabor Nemeth; York Haemisch; Philip J Blower; Paul K Marsden Journal: J Nucl Med Date: 2011-10-03 Impact factor: 10.057
Authors: Sandra Purz; Osama Sabri; Adrian Viehweger; Henryk Barthel; Regine Kluge; Ina Sorge; Franz Wolfgang Hirsch Journal: J Nucl Med Date: 2014-04-24 Impact factor: 10.057
Authors: Gaspar Delso; Sebastian Fürst; Björn Jakoby; Ralf Ladebeck; Carl Ganter; Stephan G Nekolla; Markus Schwaiger; Sibylle I Ziegler Journal: J Nucl Med Date: 2011-11-11 Impact factor: 10.057
Authors: Sergios Gatidis; Holger Schmidt; Brigitte Gücke; Ilja Bezrukov; Guido Seitz; Martin Ebinger; Matthias Reimold; Christina A Pfannenberg; Konstantin Nikolaou; Nina F Schwenzer; Jürgen F Schäfer Journal: Invest Radiol Date: 2016-01 Impact factor: 6.016
Authors: D L Bailey; G Antoch; P Bartenstein; H Barthel; A J Beer; S Bisdas; D A Bluemke; R Boellaard; C D Claussen; C Franzius; M Hacker; H Hricak; C la Fougère; B Gückel; S G Nekolla; B J Pichler; S Purz; H H Quick; O Sabri; B Sattler; J Schäfer; H Schmidt; J van den Hoff; S Voss; W Weber; H F Wehrl; T Beyer Journal: Mol Imaging Biol Date: 2015-06 Impact factor: 3.488
Authors: Jack W Power; Philip J Dempsey; Andrew Yates; Helen Fenlon; Jurgen Mulsow; Conor Shields; Carmel G Cronin Journal: Br J Radiol Date: 2021-12-08 Impact factor: 3.629
Authors: Marius E Mayerhoefer; Helmut Prosch; Lucian Beer; Dietmar Tamandl; Thomas Beyer; Christoph Hoeller; Dominik Berzaczy; Markus Raderer; Matthias Preusser; Maximilian Hochmair; Barbara Kiesewetter; Christian Scheuba; Ahmed Ba-Ssalamah; Georgios Karanikas; Julia Kesselbacher; Gerald Prager; Karin Dieckmann; Stephan Polterauer; Michael Weber; Ivo Rausch; Bernhard Brauner; Harald Eidherr; Wolfgang Wadsak; Alexander R Haug Journal: Eur J Nucl Med Mol Imaging Date: 2019-08-13 Impact factor: 9.236
Authors: Albertus Wijnand Hensbergen; Danny M van Willigen; Florian van Beurden; Pim J van Leeuwen; Tessa Buckle; Margret Schottelius; Tobias Maurer; Hans-Jürgen Wester; Fijs W B van Leeuwen Journal: Bioconjug Chem Date: 2020-01-06 Impact factor: 4.774
Authors: Marius Ovidiu Mada; Paula Hindmarch; James Stirling; James Davies; David Brian; Anna Barnes; Alexander Hammers; Nick Gulliver; Karl Herholz; John O'Brien; John-Paul Taylor Journal: Eur J Hybrid Imaging Date: 2020-01-23